• Latest Posts
More News! 24 Aug 2018

Shire gets US market approval for rare inflammatory disease drug

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

Microsoft Joins Shire to Diagnose Rare Diseases Much Faster

More News! 12 Sep 2017

Shire’s Treatment for Chronic Lung Disease in Premature Infants Fast Tracked by FDA

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases


Shire sells its RNA platform to a US-based Biotech

Results from 45% of Clinical Trials are kept Secret

Shire’s leading Pancreatic Cancer drug is Back with a Bang

The Biotech World is Buzzing: J.P. Morgan’s 2016 Phenomenon Kicks off this Week!

Collaboration is Key to Microbiomics: New Deal with The Janssen Human Microbiome Institute

Transformational deals that shaped the Biotech industry in 2015 #BIO-Europe 2015